Brightfield & Multispectral Fluorescence Imaging and Spectral Unmixing
The cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read more
Oncology
Flexible Brightfield and Fluorescence Scanning System
The modern brightfield and fluorescence scanning system by TissueGnostics offers unparalleled flexibility for researchers working on tissue-based cell culture analysis
Read more
Compact Real-time Digital Brightfield Slide Scanner
TissueGnostics has launched a new cutting-edge compact digital brightfield slide scanner with remote real-time viewing and live stitching modes combined
Read more
FDA grants BDD for Roche’s Elecsys GDF-15 assay addressing cancer weight loss
Roche has revealed that their assay Elecsys® GDF-15 assay has been approved as a companion diagnostic (CDx) in cancer therapy
Read more
Spinning Disk Confocal Imaging and High-Throughput Scanning Systems
The next-gen TissueFAXS Q confocal imaging systems are highly flexible scanning platforms which offer the advantages of both laser-free ultra-fast
Read more
Pre-assembled Microtiter Plate with Synthetic Hydrogels
The unique 3DProSeed® ready-to-use 96-well microtiter plate developed by Ectica Technologies contains pre-assembled synthetic hydrogels, ready for screening 3D cell
Read more
AI-Based HCS Image Analysis Software
The StrataQuest AI-assisted high-content screening (HCS) image cytometry software offers solutions for multiple applications in analysing large volumes of complex
Read more
High-content Screening System
The cutting-edge TissueFAXS PLUS high-content screening system by TissueGnostics is engineered for advanced multi-channel fluorescence microscopy and exceptional high-resolution imaging
Read more
Boehringer Ingelheim and Enara Bio join forces to develop new Cancer Immunotherapies
Boehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and
Read more
FDA approves Roche’s Xofluza for Influenza post-exposure prophylaxis
Roche has announced that the U.S. FDA has granted supplemental New Drug Application (sNDA) approval for Xofluza, the first single-dose
Read more